American International Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,735
| Closed | -$33.5K | – | 677 |
|
|
2024
Q1 | $33.5K | Sell |
17,735
-153
| -0.9% | -$289 | ﹤0.01% | 2860 |
|
|
2023
Q4 | $47.2K | Buy |
17,888
+640
| +4% | +$1.69K | ﹤0.01% | 2829 |
|
|
2023
Q3 | $39.7K | Buy |
17,248
+613
| +4% | +$1.41K | ﹤0.01% | 2877 |
|
|
2023
Q2 | $60.7K | Buy |
+16,635
| New | +$60.7K | ﹤0.01% | 2829 |
|
|
2022
Q2 | – | Sell |
-15,272
| Closed | -$75K | – | 3131 |
|
|
2022
Q1 | $75K | Sell |
15,272
-1,076
| -7% | -$5.28K | ﹤0.01% | 2696 |
|
|
2021
Q4 | $185K | Sell |
16,348
-488
| -3% | -$5.52K | ﹤0.01% | 2420 |
|
|
2021
Q3 | $245K | Buy |
16,836
+151
| +0.9% | +$2.2K | ﹤0.01% | 2304 |
|
|
2021
Q2 | $194 | Sell |
16,685
-530
| -3% | -$6 | ﹤0.01% | 2521 |
|
|
2021
Q1 | $210 | Buy |
17,215
+46
| +0.3% | +$1 | ﹤0.01% | 2338 |
|
|
2020
Q4 | $215 | Sell |
17,169
-36
| -0.2% | – | ﹤0.01% | 2249 |
|
|
2020
Q3 | $259K | Buy |
17,205
+246
| +1% | +$3.7K | ﹤0.01% | 1979 |
|
|
2020
Q2 | $416K | Buy |
16,959
+5,142
| +44% | +$126K | ﹤0.01% | 1692 |
|
|
2020
Q1 | $168K | Sell |
11,817
-683
| -5% | -$9.71K | ﹤0.01% | 1992 |
|
|
2019
Q4 | $198K | Buy |
12,500
+121
| +1% | +$1.92K | ﹤0.01% | 2226 |
|
|
2019
Q3 | $104K | Buy |
12,379
+907
| +8% | +$7.62K | ﹤0.01% | 2581 |
|
|
2019
Q2 | $103K | Sell |
11,472
-117
| -1% | -$1.05K | ﹤0.01% | 2662 |
|
|
2019
Q1 | $90K | Sell |
11,589
-48
| -0.4% | -$373 | ﹤0.01% | 2667 |
|
|
2018
Q4 | $55K | Sell |
11,637
-90
| -0.8% | -$425 | ﹤0.01% | 2852 |
|
|
2018
Q3 | $106K | Buy |
11,727
+211
| +2% | +$1.91K | ﹤0.01% | 2810 |
|
|
2018
Q2 | $137K | Buy |
11,516
+5,819
| +102% | +$69.2K | ﹤0.01% | 2602 |
|
|
2018
Q1 | $80K | Buy |
+5,697
| New | +$80K | ﹤0.01% | 2762 |
|